213 related articles for article (PubMed ID: 19852929)
21. Disrupted intracellular calcium regulates BACE1 gene expression via nuclear factor of activated T cells 1 (NFAT 1) signaling.
Cho HJ; Jin SM; Youn HD; Huh K; Mook-Jung I
Aging Cell; 2008 Mar; 7(2):137-47. PubMed ID: 18081741
[TBL] [Abstract][Full Text] [Related]
22. NFAT and Osterix cooperatively regulate bone formation.
Koga T; Matsui Y; Asagiri M; Kodama T; de Crombrugghe B; Nakashima K; Takayanagi H
Nat Med; 2005 Aug; 11(8):880-5. PubMed ID: 16041384
[TBL] [Abstract][Full Text] [Related]
23. Targeting calcineurin activation as a therapeutic strategy for T-cell acute lymphoblastic leukemia.
Medyouf H; Alcalde H; Berthier C; Guillemin MC; dos Santos NR; Janin A; Decaudin D; de Thé H; Ghysdael J
Nat Med; 2007 Jun; 13(6):736-41. PubMed ID: 17515895
[TBL] [Abstract][Full Text] [Related]
24. Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation.
Clipstone NA; Crabtree GR
Nature; 1992 Jun; 357(6380):695-7. PubMed ID: 1377362
[TBL] [Abstract][Full Text] [Related]
25. A preliminary examination of the role of NFAT 3 in human skin, cultured keratocytes and dermal fibroblasts.
Al-Daraji WI; Tugrul S; Dempsey E; Zelger B; Abdellaoui A; Prescott R; Zelger B
J Cutan Pathol; 2010 Sep; 37(9):e21-36. PubMed ID: 20653821
[TBL] [Abstract][Full Text] [Related]
26. [Inhibitors of NFAT-calcineurin pathway].
Miyatake S; Kaminuma O
Nihon Rinsho; 2005 Sep; 63(9):1633-9. PubMed ID: 16164223
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of calcineurin-NFAT signaling by the pyrazolopyrimidine compound NCI3.
Sieber M; Karanik M; Brandt C; Blex C; Podtschaske M; Erdmann F; Rost R; Serfling E; Liebscher J; Pätzel M; Radbruch A; Fischer G; Baumgrass R
Eur J Immunol; 2007 Sep; 37(9):2617-26. PubMed ID: 17694572
[TBL] [Abstract][Full Text] [Related]
28. Selective inhibitors of nuclear factor of activated T cells: potential therapeutic drugs for the treatment of immunological and inflammatory diseases.
Kaminuma O
Inflamm Allergy Drug Targets; 2008 Mar; 7(1):35-40. PubMed ID: 18473899
[TBL] [Abstract][Full Text] [Related]
29. The LQLP calcineurin docking site is a major determinant of the calcium-dependent activation of human TRESK background K+ channel.
Czirják G; Enyedi P
J Biol Chem; 2014 Oct; 289(43):29506-18. PubMed ID: 25202008
[TBL] [Abstract][Full Text] [Related]
30. The two-pore domain K+ channel, TRESK, is activated by the cytoplasmic calcium signal through calcineurin.
Czirják G; Tóth ZE; Enyedi P
J Biol Chem; 2004 Apr; 279(18):18550-8. PubMed ID: 14981085
[TBL] [Abstract][Full Text] [Related]
31. Selective modulation of nuclear factor of activated T-cell function in restenosis by a potent bipartite peptide inhibitor.
Yu H; Bot I; Sliedregt K; Xu X; Bot M; van Heiningen SH; van der Marel GA; Bennett MR; Overkleeft H; van Berkel TJ; Biessen EA
Circ Res; 2012 Jan; 110(2):200-10. PubMed ID: 22116820
[TBL] [Abstract][Full Text] [Related]
32. TRESK: the lone ranger of two-pore domain potassium channels.
Enyedi P; Braun G; Czirják G
Mol Cell Endocrinol; 2012 Apr; 353(1-2):75-81. PubMed ID: 22115960
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of nuclear translocation of calcineurin suppresses T-cell activation and prevents acute rejection of donor hearts.
Panther F; Strasen J; Czolbe M; Lazariotou M; Burkard N; Williams T; Lange V; Otto C; Ritter O
Transplantation; 2011 Mar; 91(6):597-604. PubMed ID: 21228752
[TBL] [Abstract][Full Text] [Related]
34. Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A.
Aramburu J; Yaffe MB; López-Rodríguez C; Cantley LC; Hogan PG; Rao A
Science; 1999 Sep; 285(5436):2129-33. PubMed ID: 10497131
[TBL] [Abstract][Full Text] [Related]
35. Inhibitors of the calcineurin/NFAT pathway.
Martínez-Martínez S; Redondo JM
Curr Med Chem; 2004 Apr; 11(8):997-1007. PubMed ID: 15078162
[TBL] [Abstract][Full Text] [Related]
36. The Role of Calcium-Calcineurin-NFAT Signaling Pathway in Health and Autoimmune Diseases.
Park YJ; Yoo SA; Kim M; Kim WU
Front Immunol; 2020; 11():195. PubMed ID: 32210952
[TBL] [Abstract][Full Text] [Related]
37. Combination of nifedipine and subtherapeutic dose of cyclosporin additively suppresses mononuclear cells activation of patients with rheumatoid arthritis and normal individuals via Ca(2+) -calcineurin-nuclear factor of activated T cells pathway.
Lai NS; Yu CL; Yin WY; Yu HC; Huang HB; Tung CH; Lu MC
Clin Exp Immunol; 2012 Apr; 168(1):78-86. PubMed ID: 22385242
[TBL] [Abstract][Full Text] [Related]
38. The mechanism of action of cyclosporin A and FK506.
Schreiber SL; Crabtree GR
Immunol Today; 1992 Apr; 13(4):136-42. PubMed ID: 1374612
[TBL] [Abstract][Full Text] [Related]
39. Intermedilysin induces EGR-1 expression through calcineurin/NFAT pathway in human cholangiocellular carcinoma cells.
Susilowati H; Okamura H; Hirota K; Shono M; Yoshida K; Murakami K; Tabata A; Nagamune H; Haneji T; Miyake Y
Biochem Biophys Res Commun; 2011 Jan; 404(1):57-61. PubMed ID: 21094139
[TBL] [Abstract][Full Text] [Related]
40. Physical interaction between calcineurin and Cav3.2 T-type Ca2+ channel modulates their functions.
Huang CH; Chen YC; Chen CC
FEBS Lett; 2013 Jun; 587(12):1723-30. PubMed ID: 23669360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
